Table 1 Clinical characteristics of the proteomics discovery cohort
Proteomics discovery cohort | Clinical groups [Total N = 120] | |||
|---|---|---|---|---|
UM | CM | SMA | CC | |
Pool N (%) | 30 (25%) | 30 (25%) | 30 (25%) | 30 (25%) |
Age (months) Median (IQR) | 43 (28–81) | 48 (36–62) | 39 (19–58) | 72 (37–96) |
Sex: F/M | 18/12 | 15/15 | 16/14 | 20/10 |
PCV (%) Median (IQR) | 31 (25–35) | 25 (20–31) | 12 (11–15) | 34 (32–35) |
Parasite densitya Median (IQR) | 45,981 (19,506–61,646) | 2252 (667–65,791) | 17,216 (1193–30,806) | N/A |